While canvassing at a Latino Super Market in Las Vegas Nevada, I spoke to a Trump supporter who has cancer and could not afford his meds. It is interesting how people’s minds work.
Former Trump supporter no more.
While off-camera, he did not want me recording at first, the man gave a strong defense of Trump even as he sat there begging for money. He was not voting against his own interest because of any of the isms. He was voting against his own interest out of ignorance based on the sources he trusted.
As we spoke I saw when he started to trust my words because I made him talk. I asked questions he answered and then I gently civilly rebutted not with statements but with leading questions he then answered in opposition to what he originally thought about healthcare policy.
When I saw where the conversation was going I asked him a second time to allow me to record because his statements could help a lot of people make the right choices. He obliged.
One can see him initially fight with himself as he came to a conclusion that was more beneficial to his personal economy and his health. It is a struggle. It is like fighting a chronic disease but we must do it.
As reported by The Hill, Trump reneged on his promise to negotiate on drug prices. Pharmaceutical companies can continue pilfering the American people.
President Trump is backing off his 2016 campaign pledge to negotiate drug prices for Medicare with pharmaceutical companies, drawing fire from Democrats after months of talks on the issue with Speaker Nancy Pelosi (D-Calif.). During his campaign, Trump famously broke with Republican orthodoxy with his support for having the government negotiate lower drug prices. “When it comes time to negotiate the cost of drugs, we are going to negotiate like crazy,” Trump said in New Hampshire in early 2016.
Pelosi’s staff spent months over the course of this year trying to get White House support for her measure to allow the government to negotiate prices for up to 250 drugs per year, with tough financial penalties for companies that refused to come to the table. But after months of holding his fire, Trump is now publicly bashing Pelosi’s bill. And while Trump still talks about the need to lower drug prices in general, he has not proposed an alternative drug price negotiation plan of his own.
Talk is cheap.
